Global Continuous Subcutaneous Insulin Infusion Therapy Market Research Report 2022

Market Analysis and Insights: Global Continuous Subcutaneous Insulin Infusion Therapy Market
An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin infusion therapy. The device configuration may vary depending on design. A traditional pump includes: the pump (including controls, processing module, and batteries); a disposable reservoir for insulin (inside the pump) a disposable infusion set, including a cannula for subcutaneous insertion (under the skin) and a tubing system to interface the insulin reservoir to the cannula. Other configurations are possible. For instance, more recent models may include disposable or semi-disposable designs for the pumping mechanism and may eliminate tubing from the infusion set.
The global Continuous Subcutaneous Insulin Infusion Therapy market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Normal accounting for % of the Continuous Subcutaneous Insulin Infusion Therapy global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Continuous Subcutaneous Insulin Infusion Therapy market size is valued at US$ million in 2021, while the North America and Europe Continuous Subcutaneous Insulin Infusion Therapy are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Continuous Subcutaneous Insulin Infusion Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Continuous Subcutaneous Insulin Infusion Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Continuous Subcutaneous Insulin Infusion Therapy market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Continuous Subcutaneous Insulin Infusion Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Continuous Subcutaneous Insulin Infusion Therapy market.
Global Continuous Subcutaneous Insulin Infusion Therapy Scope and Market Size
Continuous Subcutaneous Insulin Infusion Therapy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Continuous Subcutaneous Insulin Infusion Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Normal
Patch Pump
Segment by Application
Hospital
Retail Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Medtronic
Roche
SOOIL
Tandem Diabetes care
Insulet Corp
Valeritas
Microport

Frequently Asked Questions